RPG Life Sciences reports strong Q2 FY26 results, CFO resigns

RPG Life Sciences reported a 7.6% quarter-on-quarter and 5.5% year-on-year increase in revenue for Q2 FY26, reaching INR 181.7 crores. The EBITDA margin stood at 24.0%, reflecting improved operational efficiency. For the first half of FY26, revenue grew by 3.8% year-on-year to INR 350.6 crores. Profit before tax for the quarter was INR 4,945 lakhs and for the six months was INR 8,488 lakhs. Basic and diluted earnings per share for the quarter were INR 22.28.

The company's board of directors also approved the unaudited financial results and acknowledged the resignation of Mr. Vishal Shah from the position of chief financial officer and key managerial personnel, effective October 23, 2025, due to personal reasons. The company is actively seeking a suitable replacement. An exceptional item of INR 1,122 lakhs was recorded for the quarter and half year ended September 30, 2025, related to a gain on account of a fire incident at the API plant. The company has submitted a provisional insurance claim and received interim payments, confident of recovering the remaining loss.

Ashok Nair, managing director, highlighted the company's strengthened growth trajectory, driven by disciplined execution and a strategic focus on domestic formulations and international business expansion.